W. Schlack et al., INTRACORONARY SIN-1C DURING REPERFUSION REDUCES INFARCT SIZE IN DOG, Journal of cardiovascular pharmacology, 25(3), 1995, pp. 424-431
Reperfusion of ischemic myocardium may aggravate the ischemic state of
injury and thus augment infarct size (reperfusion injury). The aim of
this study was to reduce infarct size by an intervention at the time
of reperfusion that acts only on a reperfusion-specific pathomechanism
. It was investigated whether SIN-1C, a metabolite of molsidomine, can
protect against reperfusion injury in canine hearts in vivo. Ten anes
thetized open chest dogs underwent 1 h of left anterior descendent art
ery (LAD) occlusion and were randomly assigned to receive either Intra
coronary SIN-1C or vehicle infusion as a placebo during the first hour
of reperfusion. The infusion was adjusted to LAD flow to achieve a re
gional blood concentration of 5.10(-3) M. Infarct size was assessed by
triphenyltetrazolium staining after 6 h of reperfusion. Left ventricu
lar pressure (LVP) was similar in both groups (SIN-1C: 101 +/- 6, plac
ebo: 89 +/- 6 mm Hg, mean +/- SEM, n = 5) at the beginning of the expe
riment and did not change significantly thereafter from baseline value
s in both groups. During SIN-1C infusion, the LAD now was increased (S
IN-1C: 195 +/- 38, control: 86 +/- 17 ml/min/100 g at 30 min of reperf
usion, p < 0.05), while systemic hemodynamics remained unaltered. A re
duction in infarct size (percent of area at risk) was seen in the SIN-
1C group (11.4 +/- 2.8%) compared with the placebo group (24.4 +/- 3.9
%, p < 0.05). Infusion of papaverine (5.10(-5) M) following an identic
al protocol caused a similar vasodilation as SIN-1C, but did not reduc
e infarct size in five additional dog experiments. Infusion of SIN-1C
(2.5.10(-3) 10(-2) M) in normal myocardium in one additional dog showe
d a dose-dependent increase in LAD flow to 270%, which was paralleled
by a depression of regional wall thickening (33%). The results demonst
rate that necrosis in the reperfused myocardium can be greatly reduced
by therapeutic intervention at the onset of reperfusion. Intracoronar
y SIN-1C can be used for such an intervention. It has a pronounced loc
al protective effect, without altering systemic hemodynamics. The mech
anism of protection does not seem to be related to the coronary vasodi
latory effect of SIN-1C.